Sinclair SaTia T, Emara Ahmed K, Orr Melissa N, McConaghy Kara M, Klika Alison K, Piuzzi Nicolas S
Cleveland Clinic Foundation, Department of Orthopedic Surgery, Cleveland, Ohio, United States.
Case Western Reserve University School of Medicine, Cleveland, Ohio, United States.
EFORT Open Rev. 2021 Aug 10;6(8):629-640. doi: 10.1302/2058-5241.6.200124. eCollection 2021 Aug.
Comorbidity indices currently used to estimate negative postoperative outcomes in orthopaedic surgery were originally developed among non-orthopaedic patient populations.While current indices were initially intended to predict short-term mortality, they have since been used for other purposes as well.As the rate of hip and knee arthroplasty steadily rises, understanding the magnitude of the effect of comorbid disease on postoperative outcomes has become increasingly more important.Currently, the ASA classification is the most commonly used comorbidity measure and is systematically recorded by the majority of national arthroplasty registries.Consideration should be given to developing an updated, standardized approach for comorbidity assessment and reporting in orthopaedic surgery, especially within the setting of elective hip and knee arthroplasty. Cite this article: 2021;6:629-640. DOI: 10.1302/2058-5241.6.200124.
目前用于评估骨科手术术后不良结局的合并症指数最初是在非骨科患者群体中开发的。虽然当前的指数最初旨在预测短期死亡率，但后来也被用于其他目的。随着髋关节和膝关节置换术的发生率稳步上升，了解合并疾病对术后结局的影响程度变得越来越重要。目前，美国麻醉医师协会（ASA）分类是最常用的合并症衡量标准，并且大多数国家关节置换登记处都会系统地记录。应该考虑制定一种更新的、标准化的方法来评估和报告骨科手术中的合并症，特别是在择期髋关节和膝关节置换术的背景下。引用本文：2021；6：629 - 640。DOI：10.1302/2058 - 5241.6.200124。
